FGF21 and Hyperglycemia: Exogenous FGF21 treatment improves glucose homeostasis and prevents hyperglycaemia and diabetes in NZO mice, a model of polygenetic obesity and type 2 diabetes with the characteristic trait of pancreatic beta cell loss [11, 15].